Rich Kodama

Areas of Expertise

Conditions I Treat

  • Bacterial diseases
  • Fungal diseases
  • Human Immunodeficiency Virus (HIV)

My Specialties

  • Antibiotic management
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.
English
Share

Get to Know Me

I specialize in the diagnosis and treatment of infectious diseases. My areas of interest include:
 

  • Infection in immunocompromised people, such as those with cancer or a history of transplant
  • Human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)
  • Invasive fungal infections
  • Mycobacterial infections
  • Tickborne illnesses
  • Hospital epidemiology and infection control
Read more

Infections are one of the most common causes for setback in a patient’s cancer treatment plan. For example, an infection can affect a patient’s ability to enroll in a clinical trial, undergo more therapies, or receive hospice care at home. As an infectious diseases specialist, I am dedicated to treating these infections safely and effectively, with the goal of returning patients to their desired cancer plans as quickly as possible. Assisting in this journey to help patients reach their goals is my passion.

Outside of medicine, I enjoy bowling, martial arts, traveling abroad, and exploring cultures through food.

What I Do at MSK

I'm an infectious (in-FEK-shuhs) disease specialist. This is a doctor with special training in diseases caused by microorganisms (bacteria, fungi, parasites, and viruses).

  • Assistant Attending Physician
  • Assistant Hospital Epidemiologist
Areas of Expertise

Conditions I Treat

  • Bacterial diseases
  • Fungal diseases
  • Human Immunodeficiency Virus (HIV)
  • Acquired Immunodeficiency Syndrome (AIDS)
  • COVID-19
  • Parasitic diseases
  • Viral diseases
  • Infections in the immunocompromised

My Specialties

  • Antibiotic management
Education & Honors

Education

  • DO, A.T. Still University School of Osteopathic Medicine in Arizona

Residencies

  • Internal Medicine, NewYork-Presbyterian Brooklyn Methodist Hospital

Fellowships

  • Infectious Diseases, Memorial Sloan Kettering Cancer Center

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Current Patients
Request an appointment by logging in to MSK MyChart or calling your Care Team. If you are not enrolled in MSK MyChart, ask your Care Team to send you an invitation. You can also go to MSK MyChart and select “Sign up now.”

Contact and Location

Dr. Kodama sees patients at two locations.

Office Phone
Location
New York, NY

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Infectious Diseases Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Gaulin, C., Harris, Z., Kodama, R. et al. Fungal Infections Associated with CD19-Targeted Chimeric Antigen Receptor T Cell Therapy. Curr Fungal Infect Rep 17, 87–97 (2023). https://doi.org/10.1007/s12281-023-00460-6

Yan J, Steiger SN, Kodama R, Fender J, Tan C, Laracy J, Cohen N, McMillen T, Jani K, Robilotti EV, Babady NE, Seo SK, Kamboj M. Predictors of Coronavirus Disease 2019 Hospitalization After Sotrovimab in Patients With Hematologic Malignancy During the BA.1 Omicron Surge. Clin Infect Dis. 2023 Apr 17;76(8):1476-1482. doi: 10.1093/cid/ciac916. PMID: 36445792.

Kodama R, Arora S, Anand S, Choudhary A, Weingarten J, Francesco N, Chiricolo G, Silber S, Mehta PH. Reengineering the Discharge Transition Process of COVID-19 Patients Using Telemedicine, Remote Patient Monitoring, and Around-the-Clock Remote Patient Monitoring from the Emergency Department and Inpatient Units. Telemed J E Health. 2021 Oct;27(10):1188-1193. doi: 10.1089/tmj.2020.0459. Epub 2020 Dec 14. PMID: 33320031.

Read more

Kodama R, Bhesania S, Gorski J, Sepkowitz D. A Missionary from Sudan: Brucellosis. Am J Med. 2021 Mar;134(3):e197-e198. doi: 10.1016/j.amjmed.2020.07.038. Epub 2020 Sep 15. PMID: 32941846.

Publications on PubMed

Visit PubMed for a full listing of Dr. Kodama’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Rich Kodama discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures